Cargando…
The Selective Agonist for Sphingosine-1-Phosphate Receptors Siponimod Increases the Expression Level of NR4A Genes in Microglia Cell Line
Fingolimod (FTY720) and siponimod (BAF312) are selective agonists for sphingosine-1-phosphate (S1P) receptors approved for the treatment of relapsing–remitting (RR) and secondary progressive (SP) multiple sclerosis (MS), respectively. BAF312 exerts pro-myelination and neuro-protective functions on C...
Autores principales: | Montarolo, Francesca, Martire, Serena, Marnetto, Fabiana, Valentino, Paola, Valverde, Sabdi, Capobianco, Marco Alfonso, Bertolotto, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947415/ https://www.ncbi.nlm.nih.gov/pubmed/35723306 http://dx.doi.org/10.3390/cimb44030083 |
Ejemplares similares
-
The impact of pre-freezing storage time and temperature on gene expression of blood collected in EDTA tubes
por: Martire, Serena, et al.
Publicado: (2022) -
Rituximab-induced hypogammaglobulinemia in patients with neuromyelitis optica spectrum disorders
por: Marcinnò, Andrea, et al.
Publicado: (2018) -
Aquaporin-4 antibody titration in NMO patients treated with rituximab: A retrospective study
por: Valentino, Paola, et al.
Publicado: (2016) -
TNFAIP3 Deficiency Affects Monocytes, Monocytes-Derived Cells and Microglia in Mice
por: Montarolo, Francesca, et al.
Publicado: (2020) -
Siponimod ameliorates metabolic oligodendrocyte injury via the sphingosine-1 phosphate receptor 5
por: Behrangi, Newshan, et al.
Publicado: (2022)